Point Taken! My apologies. I welcome you to the board and

New Post Public Reply Private Reply Replies (0) Message Board
expharmer ArtistsView #42341
679
Point Taken! My apologies. I welcome you to the board and will keep myself in check. My biggest concern is getting off point and creating doubt when we know we are close and we know the science will save thousands upon thousands of lives. I just get frustrated when I consider the number of posters that are trying to harm this truly amazing drug for no other reason but to make a few bucks. You won't get anymore blank looks from me and btw it's not a scam! I have launched and sold many pharmaceuticals over the past 20 years. I know a good drug when I see one. We have the MOA, we have the safety data and soon we will have the trial outcomes. We have manufacturing and distribution and large number of well respected physicians and leaders who believe this drug is "the real deal"

By best to you.

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Workhorse Group Battles Nasdaq Compliance Amid Financial Woes

Updated Category News Views 87

Workhorse Group Faces Nasdaq Compliance Challenges Workhorse Group Inc (NASDAQ: WKHS), a manufacturer in the electric vehicle sector, has recently been issued a notice by the Nasdaq Stock Market regarding its non-compliance with the minimum bid price requirement. The pressing issue arises from the company's common stock trading below the $1.00 mark for a continuous period...

Continue Reading
Investors Have a Deadline to Join NET Power Class Action

Updated Category News Views 293

Investors Have a Deadline to Join NET Power Class Action In a significant turn of events, Kahn Swick & Foti, LLC advises investors who’ve incurred losses exceeding $100,000 in NET Power Inc. to take action. If you are among those affected, the time is critical. You have until June 17, 2025 to file your lead plaintiff application in this securities class action lawsuit...

Continue Reading
New Developments in Borregaard ASA's Share Transactions

Updated Category News Views 152

Insight into Recent Share Purchases at Borregaard ASA Recently, significant transactions have emerged within Borregaard ASA that are noteworthy for investors and stakeholders alike. Tove Andersen, a dedicated member of the board, made headlines by acquiring 2,000 shares at a price of NOK 187.92 each. This purchase marks a decisive move, increasing her total holdings to...

Continue Reading
Guaranteed Roof Enhances Commercial Roofing Options in NC

Updated Category News Views 136

Guaranteed Roof Enhances Commercial Roofing Options in North Carolina Guaranteed Roof, recognized for its expertise in roof rejuvenation and replacement services, is excited to announce a major enhancement to its commercial division. This initiative strongly emphasizes the utilization of FAR Coatings, a cutting-edge solution for flat and low-slope roofs. By leveraging...

Continue Reading
Key Details for Sage Therapeutics, Inc. Investors Ahead of Deadline

Updated Category News Views 38

Understanding the Class Action for Sage Therapeutics, Inc. As a diligent investor, knowing your rights is crucial, especially when involved with companies like Sage Therapeutics, Inc. (NASDAQ: SAGE). If you purchased securities between specific dates, it’s essential to pay attention to upcoming deadlines. The Importance of the Deadline The Rosen Law Firm, a leading...

Continue Reading